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Summary 
The poly(ADP-ribose)polymerase (PARP) Tankyrase (TNKS, TNKS2) is paramount to Wnt-β-
catenin signalling and a promising therapeutic target in Wnt-dependent cancers. The pool of active 
β-catenin is normally limited by destruction complexes, whose assembly depends on the polymeric 
master scaffolding protein AXIN. Tankyrase, which poly(ADP-ribosyl)ates and thereby destabilises 
AXIN, can also polymerise, but the relevance of these polymers has remained unclear. We report 
crystal structures of the polymerising TNKS and TNKS2 sterile alpha motif (SAM) domains, 
revealing versatile head-to-tail interactions. Biochemical studies informed by these structures 
demonstrate that polymerisation is required for Tankyrase to drive β-catenin-dependent 
transcription. We show that the polymeric state supports PARP activity and allows Tankyrase to 
effectively access destruction complexes through enabling avidity-dependent AXIN binding. This 
study provides an example for regulated signal transduction in non-membrane enclosed 
compartments (signalosomes) and points to novel potential strategies to inhibit Tankyrase function 
in oncogenic Wnt signalling. 
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Introduction 
Signal transduction often occurs through large and transient multi-protein complexes. 
Polymerising proteins can nucleate the assembly of higher-order structures termed signalosomes, 
which enable locally increased protein concentrations for efficient, transient and spatially confined 
processes (Bienz, 2014; Wu, 2013). Wnt-β-catenin signalling, which is dysregulated in most 
colorectal cancers, provides prominent examples for signalosomes (Bienz, 2014; Polakis, 2012). At 
basal signalling, a destruction complex (DC) composed of the scaffolding proteins AXIN and 
adenomatous polyposis coli (APC), glycogen synthase kinase 3 (GSK3) and casein kinase 1 (CK1) 
captures and phosphorylates β-catenin to initiate its degradation (Stamos and Weis, 2013). AXIN is 
the central and concentration-limiting component of the DC (Lee et al., 2003; Stamos and Weis, 
2013). Microscopically, DCs manifest as dynamic puncta with a filamentous sub-organisation, so-
called β-catenin degradasomes, whose formation is dependent on AXIN polymerisation (Fiedler et 
al., 2011; de la Roche et al., 2014; Martino-Echarri et al., 2016; Thorvaldsen et al., 2015). 
The poly(ADP-ribose)polymerases (PARPs) Tankyrase (TNKS, ARTD5) and Tankyrase 2 
(TNKS2, ARTD6) regulate Wnt-β-catenin signalling (Huang et al., 2009). We will refer to TNKS 
and TNKS2 collectively as “Tankyrase” where principles apply to both. Tankyrase binds and 
poly(ADP-ribosyl)ates (PARylates) AXIN, targeting it for PAR-dependent ubiquitination (PARdU) 
and degradation to stabilise transcriptionally active β-catenin (Callow et al., 2011; DaRosa et al., 
2014; Huang et al., 2009; Morrone et al., 2012; Zhang et al., 2011). Tankyrase buffers negative 
regulation of Wnt signalling by AXIN for robust pathway activation (Wang et al., 2016). Upon Wnt 
stimulation, AXIN PARylation by Tankyrase promotes its function in active signalling complexes 
(Yang et al., 2016). 
The two Tankyrases are highly similar (Hsiao and Smith, 2008; Smith, 1998) (Figure 1A), 
sharing a set of five ankyrin repeat clusters (ARCs) for substrate binding (Guettler et al., 2011; 
Seimiya et al., 2004), a sterile alpha motif (SAM) domain (De Rycker and Price, 2004; De Rycker 
et al., 2003) and a catalytic PARP domain (Rippmann et al., 2002). Tankyrase’s biological 
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functions are complex (Haikarainen et al., 2014), and simultaneous loss of both Tankyrases results 
in embryonic lethality in mice (Chiang et al., 2008). Besides Wnt signalling, Tankyrase contributes 
to telomere maintenance (Canudas et al., 2007; Dynek, 2004; Smith, 1998), both critical to stem 
cell renewal, development and certain types of cancer (Bernardes de Jesus and Blasco, 2013; 
Clevers et al., 2014). Given these functions and a dependency of BRCA1/2-deficient cancer cells on 
Tankyrase (McCabe et al., 2009), Tankyrase is a promising anti-cancer target (Haikarainen et al., 
2014; Lehtiö et al., 2013; Riffell et al., 2012). 
It is intriguing that Tankyrase, like AXIN, polymerises (De Rycker and Price, 2004; De 
Rycker et al., 2003). Tankyrase polymerisation is mediated by the SAM domain, a small helical 
fold highly prevalent in eukaryotes (Knight et al., 2011; Qiao and Bowie, 2005). The structural 
basis of Tankyrase polymerisation and its function has remained unknown. Moreover, we currently 
lack insight into the regulation of Tankyrase activity. 
Here we show that Tankyrase can induce Wnt-β-catenin signalling independently of its 
catalytic activity, through ARC- and SAM-domain dependent scaffolding. This redefines our view 
on pharmacologic inhibition of Tankyrase. Informed by crystal structures of the TNKS and TNKS2 
SAM domains, we demonstrate that Tankyrase polymerisation is critical for its function in Wnt 
signalling, required for full PARP activity, and necessary for efficient interaction with AXIN. We 
propose a model in which recruitment of Tankyrase to β-catenin DCs is promoted by avidity effects 
that arise from multivalency and polymerisation inherent to the Tankyrase-AXIN complex. 
 
 
Results 
Tankyrase requires ARCs and SAM domain to promote Wnt signalling 
To explore the domain requirements of Tankyrase for Wnt-β-catenin signalling, we 
measured β-catenin/TCF/LEF-dependent transcription in reporter assays. While basal Wnt 
signalling in HEK293T cells is low (Li et al., 2012), expression of TNKS or TNKS2 activated the 
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reporter in a specific, dose-dependent manner (Figure 1B; see Figure S1 for protein expression 
levels). Intriguingly, reporter activation by either TNKS or TNKS2 was not abolished but merely 
reduced by ≈50% when poly- and mono(ADP-ribosyl)ation were inactivated by point mutation 
(G1185WT1, G1032WT2; Figures 1B and F) (Yu et al., 2005). Likewise, mutation of a glutamate 
that is part of the catalytic H-Y-E triad (E1291AT1, E1138AT2) (Hottiger et al., 2010), or deletion of 
the PARP domain altogether, did not abolish reporter activation (Figures 1C and F). Concordantly, 
saturating concentrations of the Tankyrase inhibitor XAV939 reduced TNKS2-dependent reporter 
activation only to a level that was also conferred by PARP-inactive TNKS2 G1032WT2 (Figures 1D 
and S2A). This suggests that both catalysis-dependent and -independent functions of Tankyrase 
contribute to Wnt signalling. We hypothesised that scaffolding through the SAM domain and ARCs 
contribute to signalling. Deletion of the SAM domain fully abrogated Tankyrase-dependent reporter 
activation (Figure 1B), as did deletion of all ARCs or mutation of ARCs 1, 2, 4 and 5 (mutant 
xx3xx) to prevent substrate binding (Guettler et al., 2011) without impairing catalysis (Figures 1E 
and F). Our observations expand upon and are in line with previous deletion studies (Huang et al., 
2009). ARCs and SAM domain may collaborate in recruiting Tankyrase to AXIN and/or facilitate 
productive PARylation. Overexpression of Tankyrase-binding deficient, but not wild-type AXIN1 
impeded TNKS2-dependent Wnt signalling (Figure S2B). This is in agreement with Tankyrase 
activating Wnt-β-catenin signalling at the level of AXIN and illustrates the strong buffering 
capacity of Tankyrase toward AXIN (Huang et al., 2009; Wang et al., 2016). 
 
Polymerisation of TNKS and TNKS2 SAM domains 
AXIN binding by the Tankyrase ARCs is well understood (Guettler et al., 2011; Huang et 
al., 2009; Morrone et al., 2012). Conversely, it remains unclear how the SAM domain enables 
Tankyrase function in Wnt signalling, and whether polymerisation is involved. To study SAM 
domain polymerisation, we performed ultracentrifugation sedimentation assays, in which polymers 
of purified SAM domains partition into the pellet (Figure 2A). While the TNKS2 SAM domain 
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readily sedimented, that of TNKS did not, suggesting that TNKS SAM forms less stable polymers 
in vitro (Figure 2A). We observed filaments for both the TNKS2 and TNKS SAM domains by 
electron microscopy (EM), but TNKS SAM required higher concentrations to form visible 
filaments (Figure 2B). Based on a homology model (not shown), we generated a DH902/924RET2 
mutant of the TNKS2 SAM domain, which failed to sediment (Figure 2A). 
We next analysed highly purified SAM domains by size exclusion chromatography with in-
line multi-angle light scattering (SEC-MALS), which is more sensitive than the sedimentation 
assay. When analysed at 0.5 mM, the TNKS2 SAM domain (theoretical MW ≈9 kDa) eluted as 
polydisperse assemblies of overall 1965 ± 329 kDa, clearly indicating polymerisation (Figure 2C). 
For 0.5 and 2 mM TNKS SAM, we detected polydisperse assemblies of 33.9 ± 1.8 kDa and 65.3 ± 
2.3 kDa, respectively (Figure 2C), confirming that TNKS SAM also polymerises, although to a 
lesser extent. We found that differential polymerisation of the TNKS and TNKS2 SAM domains is 
largely due to a single amino acid difference (T1049T1 and R896T2, Figures S2C and D). However, 
transcription reporter assays with TNKS/TNKS2 SAM domain chimeras and interconverting point 
mutants (T1049RT1, R896TT2) showed that both SAM domains equally enable Tankyrase to drive 
Wnt signalling (Figure S2E). Thus, the SAM domain may either promote Tankyrase function 
independently of its polymerisation, or the lower polymerisation of TNKS may still be sufficient for 
Wnt signalling under the assay conditions. In the latter case, a substantial impairment of 
TNKS/TNKS2 polymerisation would abrogate Tankyrase-dependent Wnt signalling. 
 
Crystal structures of TNKS2 and TNKS SAM domains 
To enable the generation of well-defined Tankyrase mutants, we crystallised the TNKS2 
SAM domain. Since polymerisation was likely to hinder crystallisation, we used the 
polymerisation-impaired DH902/924RET2 mutant. Reasoning that the mutant domain would still 
retain most polymerisation interface residues, polymer contacts would be recoverable at the high 
protein concentration during crysallisation, as illustrated for other polymerising SAM domains 
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(Kim et al., 2001; 2002). We obtained well-diffracting crystals (1.53 Å) and solved the structure by 
molecular replacement (Table 1 and Extended Experimental Procedures). The TNKS2 SAM 
domain, a 5-α-helix bundle similar to other SAM domains, forms a left-handed helix with a pitch of 
46 Å, whose axis coincides with the crystallographic P65 screw axis (Figure 3A). The SAM 
domains interact in the well-established end-helix (EH) – mid-loop (ML) binding mode (Qiao and 
Bowie, 2005) (Figures 3B and D). On the EH surface, basic electrostatic potential predominates 
while the ML surface is predominantly acidic, in line with the salt sensitivity of the polymer 
(Figures 3B and C). The closest approach between the two surfaces occurs around the N-terminus 
of helix α5, where EH-surface residues A919T2, Y920T2, G921T2, H922T2 engage in a network of 
hydrogen bonds and van-der-Waals contacts (Figure 3D). H922T2 and A919T2 contact the Q898T2 
side chain. Y920T2 is the most buried side chain at the interface (125 Å2), interacting with various 
hydrophobic ML side chains (V903T2, I899T2, I915T2 and M907T2), which collectively form a 
shallow pocket, as well as E911T2 and E897T2. In turn, E897T2 binds the protein main chain at 
A919T2 and Y920T2. The main chains of adjacent SAM domains interact between G921T2 and 
E897T2/Q898T2. The interface opens up toward the outside of the filament. In its non-mutated form, 
D902T2 likely forms a salt bridge with R932T2, which may promote another salt bridge between 
K928T2 and E906T2. Surprisingly, despite its importance for TNKS2 SAM domain polymerisation, 
R896T2 is not involved in any contact (Figure 3D). 
We also crystallised the TNKS SAM domain, which again required a polymer-breaking 
mutation. TNKS SAM D1055RT1, equivalent to D902RT2, produced two crystal forms in space 
group P21, diffracting to 2.5 Å (crystal form 1) and 2.9 Å (crystal form 2), both with six molecules 
in distinct asymmetric units (Table 1, Figures 4A and B, Figure S4). The TNKS SAM domain is 
highly similar to that of TNKS2 (Figure 4C, left). For both TNKS crystal forms, non-
crystallographic and crystallographic symmetry give rise to left-handed helical filaments 
established by EH-ML contacts (Figures 4A and B, Figure S4). The repeating unit consists of six 
SAM domains with pitches of 83 and 79 Å, almost twice as long as for TNKS2 (Figures 4A and 
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4B). Unlike for TNKS2, where protomer contacts rely on crystallographic symmetry only and are 
therefore uniform, the TNKS SAM EH-ML contacts vary substantially. This is apparent from the 
approximate six-fold axial symmetry and the variable tilt and twist between adjacent SAM domains 
(Figures S4 and 4C). The three crystal structures provide snapshots of 13 unique SAM domain 
pairs. Many contacts are shared between all EH-ML interactions, but a subset is specific to certain 
binding geometries, sometimes involving the same residue in alternative interactions (Figures 4D 
and S4C). We conjecture that the variable relative orientations of SAM domains reflect filament 
flexibility (Figure 2B). SAM-SAM interface residues are conserved across a wide range of phyla, 
including poriferans, indicating that polymerisation is a common and ‘ancient’ feature of Tankyrase 
(Figures 4D and E). 
 
Characterisation of polymer contacts by mutagenesis 
We performed site-directed mutagenesis of the TNKS2 SAM domain and assessed 
polymerisation by ultracentrifugation sedimentation. Mutations either strongly, intermediately or 
weakly abrogated sedimentation (Figure 5A). In most cases, mutation of robust TNKS2 SAM 
contact residues (Y920T2, H924T2, E897T2, V903T2) strongly impaired polymerisation, as did 
mutation of E906T2, K913T2 and K928T2. Although situated close to the SAM-SAM interface, the 
latter three form no explicit contacts in the TNKS2 SAM crystal structure (Figures 3D and 4D). 
However, the equivalent residues (D1059T1, K1066T1, K1081T1, respectively) mediate binding 
between a subset of protomers in the TNKS SAM crystal structures (Figures 4D and S4C). Thus, 
contacts not seen in all SAM-SAM pairs are still generally relevant, probably occurring in some but 
not all configurations of the flexible filament. 
We used SEC-MALS and EM to validate strong mutations (V903WT2, E906KT2, K913ET2, 
Y920AT2, H924ET2 and a VY903/920WAT2 combination). Except for E906KT2 and K913ET2, all 
mutations conferred monomeric behaviour (Figures 5B and C). TNKS2 SAM K913ET2 and 
E906KT2 showed considerable residual polymerisation (Figures 5B and S3F); we hence re-assigned 
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their polymer-breaking scores to ‘intermediate’. As for TNKS2 SAM, the TNKS SAM mutations 
V1056WT1, Y1073AT1 and VY1056/1073WAT1 strongly abrogated polymerisation (Figure 5B). CD 
spectroscopy showed that the mutations did not impair SAM domain folding (Figures S5A and B). 
Combining SAM domains with strong mutations in opposite polymerisation surfaces (ML: 
V1056WT1, V903WT2; EH: Y1073AT1, Y920AT2) gave rise to homo- and heterotypic dimers 
(Figures S3D and E). This enabled us to assess the SAM-SAM binding affinities by isothermal 
titration calorimetry (ITC). TNKS and TNKS2 SAM domains bound homo- and heterotypically 
with comparable, low-micromolar affinities, typical for dynamic protein-protein interactions 
(Figures 5D and S5C; see Discussion). 
 
Full-length Tankyrases interact through EH and ML SAM domain surfaces 
We assessed self-interaction of full-length Tankyrases in co-immunoprecipitations with 
wild-type Tankyrases as bait. Robust homotypic binding of TNKS and TNKS2 was abolished by 
SAM domain deletion or mutation of both the ML and EH surfaces (VY1056/1073WAT1, 
VY903/920WAT2), and reduced by mutation of either the ML (V1056WT1, V903WT2) or EH 
surface (Y1073AT1, Y920AT2) alone (Figure 6A, left and centre). We also detected heterotypic 
binding of TNKS and TNKS2 and confirmed its sensitivity to SAM domain mutations (Figure 6A, 
right). The SAM domain was previously shown to confer high apparent molecular weight to TNKS 
in gel filtration experiments (De Rycker and Price, 2004). Using the VY1056/1073WAT1 and 
VY903/920WAT2 point mutants, we tested whether this reflects Tankyrase polymerisation. Wild-
type TNKS and TNKS2 eluted close to the void volume with subsequent trails (Figure S6A). Both 
deletion and point mutation of the SAM domain resulted in an elution delay and increased trailing 
with an emerging late elution peak. We detected endogenous TNKS in both the early and late 
peaks, suggesting that TNKS exists in heterogeneous polymerisation states (Figure S6A), but were 
unable to detect endogenous TNKS2. Collectively, co-immunoprecipiation and gel filtration show 
that full-length Tankyrases homo- and heteropolymerise. Using both assays, we found no evidence 
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for modulated polymerisation of full-length TNKS or TNKS2 by the T1049RT1 or R896TT2 
mutations, suggesting that differential polymerisation may not occur in full-length context or only 
under particular conditions (Figure S6A and B). 
 
Polymerisation controls Tankyrase subcellular localisation 
 To address if polymerisation affects Tankyrase subcellular localisation, we imaged HeLa 
cells expressing mCitrine- and mCherry-tagged TNKS or TNKS2. Since Tankyrase PARP activity 
was proposed to inhibit polymerisation (De Rycker and Price, 2004), we compared vehicle- and 
XAV939-treated cells (Figure 6B). Both mCherry-TNKS and -TNKS2 displayed a punctate, 
predominantly cytoplasmic distribution, with more pronounced puncta upon XAV939 treatment 
(Figure 6B). In contrast, co-expressed mCitrine-tagged non-polymerising EH/ML double mutants 
(VY1056/1073WAT1, VY903/920WAT2) displayed mostly diffuse localisation, even in the presence 
of XAV939 (Figure 6B; see Figure S6C for additional controls). This shows that polymerisation 
enables the assembly of both TNKS and TNKS2 higher-order structures. In line with 
heteropolymerisation, differentially tagged TNKS and TNKS2 colocalised (Figure S6D). 
 
Polymerisation is required for Tankyrase-dependent Wnt signalling 
We tested how SAM domain mutations affect the ability of TNKS2 to drive Wnt signalling. 
We observed a correlation between the severity of the polymerisation defect and diminished 
transcription reporter activity (Figure 6C). Likewise, strong polymer-breaking mutations abolished 
Wnt signalling induced by TNKS (Figure 6D). Transcription reporter assays using paired TNKS2 
mutants with inactivated opposite SAM domain faces suggest that Tankyrase dimerisation is 
insufficient to drive Wnt signalling (Figure S7A). A heterologous polymerising SAM domain, that 
of D. melanogaster Polyhomeotic (Kim et al., 2002), only partially compensated for SAM domain 
loss in TNKS2; however, the partial rescue was dependent on polymerisation (Figures S7B-E). In 
conclusion, SAM domain polymerisation enables Tankyrase function in Wnt-β-catenin signalling. 
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Polymerisation promotes Tankyrase PARP activity and interaction with AXIN 
To explore the mechanism by which Tankyrase polymerisation promotes Wnt signalling, we 
assessed the in-vitro auto-PARylation activity of immunoprecipitated MYC2-TNKS2 WT, 
ΔSAMT2, V903WT2, Y920AT2 and the catalytically inactive variant G1032WT2. We readily 
observed TNKS2-dependent PARylation (Figure 7A). The ΔSAMT2, V903WT2, Y920AT2 mutations 
reduced PARylation by ≈40 to 50 % and also accounted for strongly reduced endogenous 
PARylation, prior to the in-vitro reaction (Figure 7A). Our observations agree with previous reports 
of reduced TNKS/TNKS2 activity upon SAM domain deletion (De Rycker and Price, 2004; Levaot 
et al., 2011) and clarify that polymerisation is required. To evaluate PARylation processivity, we 
detached PAR chains from the proteins and analysed their size distribution. PAR from TNKS2 
wild-type, V903WT2 and Y920AT2 showed similar lengths, indicating that polymerisation does not 
affect auto-PARylation processivity (Figure 7B). Conversely, TNKS2 ΔSAMT2 produced overall 
shorter PAR chains (Figure 7B), suggesting that the SAM domain may impact PAR chain length 
independently of its polymerisation. 
We next asked whether Tankyrase polymerisation promotes its interaction with AXIN. In 
colorectal cancer cells, but not HeLa cells with their intact Wnt-β-catenin pathway, Tankyrase and 
AXIN1/2 have been shown to colocalise in β-catenin degradasomes induced by Tankyrase 
inhibitors (de la Roche et al., 2014; Martino-Echarri et al., 2016; Thorvaldsen et al., 2015). We 
hence analysed SW480 colorectal cancer cells and observed that transiently expressed MYC2-
TNKS2 and endogenous AXIN2 accumulate in puncta upon XAV939 treatment (Figure 7C). 
Provided AXIN2 levels were sufficient for immunodetection, TNKS2 colocalised with AXIN2 in 
degradasomes (Figure 7C). Deletion or mutation of the SAM domain (ΔSAMT2, VY902/920WAT2) 
resulted in a more diffuse TNKS2 localisation; however, we still detected substantial co-localisation 
of these mutants with AXIN2 puncta, likely due to the interaction of the ARCs with AXIN at 
overexpression levels of Tankyrase. Inactivation of the ARCs (xx3xx) did not abolish puncta 
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formation by TNKS2 but substantially reduced its colocalisation with AXIN2 foci (Figure 7C). The 
retained colocalisation may reflect residual AXIN2 binding by the xx3xx mutant and/or additional 
determinants, including bridging through endogenous Tankyrase. When combined with the xx3xx 
mutations, the ΔSAMT2 or VY902/920WAT2 mutations resulted in diffuse TNKS2 staining without 
colocalisation in AXIN2 puncta (Figure 7C). Thus, polymerisation contributes to the recruitment of 
TNKS2 to β-catenin degradasomes. 
To more directly evaluate if Tankyrase polymerisation promotes AXIN binding, we 
immunoprecipitated endogenous AXIN1 from HEK293T cells (avoiding AXIN overexpression to 
maintain limiting levels) and assessed its binding to MYC2-TNKS2 (Figure 7D). AXIN1 robustly 
bound to TNKS2 and its catalytically inactive mutant G1032WT2. However, recovery of TNKS2 
ΔSAMT2, V903WT2, Y920AT2 and the xx3xx mutant was strongly reduced (Figure 7D). Taken 
together, the microscopy and binding studies illustrate that SAM-domain mediated polymerisation 
promotes Tankyrase interaction with AXIN in β-catenin degradasomes. 
 
 
Discussion 
We propose a model in which multivalency, mediated by two Tankyrase-binding motifs in 
AXIN (Morrone et al., 2012) and four AXIN-binding ARCs in Tankyrase (Guettler et al., 2011), 
combined with polymerisation of both proteins, gives rise to avidity for efficient Tankyrase 
recruitment to DCs (Figure 7E). Additionally, Tankyrase polymerisation supports auto-PARylation, 
promoting recruitment and activity of the E3 ubiquitin ligase RNF146, which also binds the ARCs 
(DaRosa et al., 2014). Our observation that Tankyrase-mediated scaffolding can drive Wnt-β-
catenin signalling independently of catalytic PARP activity has important implications for the use 
of Tankyrase inhibitors to oppose oncogenic Wnt signalling. 
The SAM-SAM contacts seen in our crystal structures are relevant to the full-length 
proteins. Firstly, the SAM domains present their termini toward the filament periphery, compatible 
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with protruding ARCs and PARP domains (Knight et al., 2011). Secondly, Tankyrase 
polymerisation and its ability to activate β-catenin dependent transcription correlate, and 
mutagenesis suggests that activation may require a TNKS- and TNKS2-specific polymerisation 
threshold to be surpassed. Thirdly, in co-immunoprecipitation, gel filtration and light microscopy, 
full-length Tankyrases respond to mutation of the identified head-to-tail interfaces, in line with 
previous deletion studies (De Rycker and Price, 2004; Hatsugai et al., 2010). Tankyrase polymers 
display a punctate localisation, as observed for other polymerisers such as AXIN and Dishevelled in 
Wnt signalling (Fiedler et al., 2011; Schwarz-Romond et al., 2007a; 2007b), Polyhomeotic 
orthologues in transcriptional repression (Isono et al., 2013), and proteins of Supramolecular 
Organising Centres (SMOCs) in innate immune signalling (Kagan et al., 2014; Sherman et al., 
2012). Puncta were also observed for endogenous Tankyrase in XAV939-treated colorectal cancer 
cells (de la Roche et al., 2014). Correlative light and electron microscopy showed that β-catenin 
DCs are of a filamentous sub-organisation (Thorvaldsen et al., 2015). That these filaments do not 
grow to substantial length in cells likely reflects their dynamic nature (Bienz, 2014), a view 
compatible with micromolar SAM-SAM affinities and nanomolar Tankyrase concentrations in cells 
(Hein et al., 2015). 
Compared to the TNKS2 SAM domain, that of TNKS polymerises less efficiently. The 
higher molecular weight reported for chicken Tnks SAM polymers (De Rycker and Price, 2004) is 
based on elution volume rather than static light scattering and likely affected by the globular affinity 
tag and long flexible termini in the construct. Chicken MBP-Tnks SAM filaments are thus likely to 
be of similar length to the human TNKS SAM filaments analysed here. R896T2, responsible for 
differential polymerisation of isolated TNKS and TNKS2 SAM domains, or a basic residue, is 
conserved across TNKS2 orthologues and Tankyrases from species lacking TNKS2 (Figure 4D). 
However, its role remains unclear. Firstly, our crystal structures do not reveal how R896T2 
contributes to polymerisation. Although all crystal structures of polymerising SAM domains to date 
support the EH-ML interaction mode (Harada et al., 2008; Kim et al., 2001; 2002; Leettola et al., 
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2014; Nanyes et al., 2014; Stafford et al., 2011), crystallisation may impose constraints onto some 
aspects of filament architecture and conceal the role of R896T2. Secondly, TNKS and TNKS2 SAM 
domain affinities are similar by ITC, suggesting that the differences only become apparent in the 
context of wild-type filaments rather than pairs of mutant SAM domains. Thirdly, the TNKS and 
TNKS2 SAM domains are mutually interchangeable for Wnt signalling, and the interconverting 
T1049RT1 and R896TT2 mutations do not appear to affect polymerisation of the full-length proteins. 
Thus, differential polymerisation may not occur in full-length Tankyrases, or require a yet unknown 
regulatory event. Given their heteropolymerisation, the TNKS and TNKS2 pools may in fact not be 
separable. 
Surprisingly, Tankyrase can induce β-catenin dependent transcription independently of its 
catalytic PARP activity. The underlying mechanism relies on ARC- and SAM-domain dependent 
scaffolding, but remains incompletely understood. Inactive Tankyrase may have a direct role in 
establishing β-catenin degradasomes (Martino-Echarri et al., 2016). TNKS or TNKS2 
overexpression, either at the mRNA or protein level, has been described in numerous malignancies, 
including gastric (Gao et al., 2011; Matsutani et al., 2001), breast (Gelmini et al., 2004) and bladder 
cancer (Gelmini et al., 2007), astrocytoma (Tang et al., 2012), glioblastoma (Shervington et al., 
2007), pancreatic (Zhao et al., 2009), lung (Busch et al., 2013) and colon cancer (Gelmini et al., 
2006; Shebzukhov et al., 2008). Polymerisation and thus catalysis-independent Tankyrase functions 
may prevail when Tankyrase is overexpressed. Therefore, the effectiveness of catalytic Tankyrase 
inhibitors may be limited when Tankyrase levels are high (see Figure 1D). Likewise, Tankyrase 
inhibitors stabilise Tankyrases through the blockage of PARdU (Huang et al., 2009), which may 
exacerbate polymerisation. Blockage of scaffolding provides an additional promising avenue for 
pharmacologic inhibition of Tankyrase function. 
Roles of polymeric Tankyrase likely extend beyond Wnt signalling, given the high 
prevalence of Tankyrase-binding proteins (Guettler et al., 2011). In analogy to SAM-domain 
containing transcriptional regulators (Isono et al., 2013), Tankyrase polymerisation may facilitate 
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protein regulation over an extensive physical range. Two such examples may be telomeres (Hsiao 
and Smith, 2008) and DNA repair sites (Nagy et al., 2016). Conversely, polymerisation may 
suppress Tankyrase function in some cellular contexts. This study provides the tools to explore 
these questions. 
 
 
Experimental Procedures 
Extended Experimental Procedures are available in the Supplemental Information online. 
 
Luciferase Reporters 
HEK293T cells were transfected in technical triplicate with TOPFlash or FOPFlash reporter 
plasmids (Veeman et al., 2003), a reference Renilla luciferase reporter and the indicated Tankyrase 
or AXIN constructs. One replicate was analysed for protein expression. Cells were maintained in 
low serum (DMEM with 0.3% FBS) following transfection or treated with XAV939. Luciferase 
activities were measured 24 h after transfection complex addition and Renilla luciferase activity 
used for normalisation. Data were analysed as detailed in the figure legends. 
 
Protein Expression and Purification 
SAM domains of human TNKS (1018-1093) and TNKS2 (867-940) were expressed in E. coli 
as His6-MBP-Asn10 fusion proteins and purified by Ni affinity purification, tag removal, anion 
exchange and size exclusion chromatography. Proteins were dialysed into buffer with 200 mM 
NaCl prior to experiments. Proteins shown in Figures 3C and 5A were affinity-purified. 
 
Crystallisation, Structure Determination and Analysis 
Crystals of TNKS2 SAM DH902/924RET2 and TNKS SAM D1055RT1 were grown and 
analysed as detailed in Extended Experimental Procedures. Crystal structures were determined by 
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molecular replacement (Table 1). Structure coordinates and experimental structure factors have 
been deposited in the Protein Data Bank (PDB IDs 5JRT, 5JU5 and 5JTI). Interface residues were 
calculated using PISA (Krissinel and Henrick, 2007); contacts were analysed and structural 
representations generated using UCSF Chimera (Pettersen et al., 2004). 
 
Ultracentrifugation Sedimentation 
SAM domains were centrifuged at an average speed of 200,000 x g at 20 °C for 1 h. Total, 
supernatant and pellet samples were analysed by SDS-PAGE and Coomassie staining. 
 
Electron Microscopy 
SAM domains were applied to glow-discharged carbon-coated grids, negatively stained with 
2% (w/v) uranyl acetate and imaged on an FEI Tecnai 12 electron microscope. 
 
SEC-MALS 
Proteins were resolved by size exclusion in a buffer with 200 mM NaCl. In-line light 
scattering was measured using a DAWN Heleos-II (Wyatt) and refractive index using an Optilab 
rEX (Wyatt). Overall weight-average molecular weight (Mw) and dispersity (Đ) were calculated 
from two separate experiments analysed in ASTRA (Wyatt). 
 
Isothermal Titration Calorimetry 
All proteins were dialysed into binding buffer with 200 mM NaCl. TNKS2 SAM Y920AT2 
or TNKS SAM Y1073AT1 (500 µM) were injected in 2-µl increments into TNKS2 SAM V903WT2 
or TNKS SAM V1056WT1 (50 µM) or buffer, using an ITC200 MicroCalorimeter (MicroCal/GE 
Healthcare). Data were processed using Origin7 (MicroCal/GE Healthcare) using a one-site binding 
model. 
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In-vitro PARylation 
MYC2-TNKS2 and derivatives were expressed in HEK293T cells and immunoprecipitated. 
PARP activity assays were performed with 1 mM NAD+ and 5 µCi 32P-NAD+ for 30 min at 30 °C. 
PAR chains were detached and analysed essentially as described previously (Alvarez-Gonzalez and 
Jacobson, 1987; Panzeter and Althaus, 1990). Immunoprecipitates and in-vitro reactions were 
analysed by Western blotting and autoradiography, respectively. 
 
Co- Immunoprecipitations 
HEK293T cells were transfected with the indicated Tankyrase or control constructs. For 
Figure 7D, cells were serum-starved to match luciferase assays; immunoprecipitates with anti-
AXIN1 (C76H11 clone, Cell Signaling Technologies) or control IgG (sc-2027, Santa Cruz 
Biotechnology) were captured on Protein A/G magnetic resin (Thermo/Pierce). For Figures 6A and 
S6B, immunoprecipitations were performed with anti-FLAG M2 affinity gel (Sigma). Lysates and 
immunoprecipitates were analysed by SDS-PAGE and Western blotting. 
 
Fluorescence Microscopy 
 HeLa or SW480 cells were transiently transfected with the indicated Tankyrase constructs. 
Cells in DMEM containing 0.3% FBS were treated either with DMSO vehicle or 2 µM XAV939 
for 20 h directly after transfection. Cells were fixed by addition of 4% formaldehyde. Cells were 
immuno- and DAPI-stained as indicated. 
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Figure Legends 
 
Figure 1: Requirement of ARCs and SAM domains for Tankyrase-driven Wnt signalling 
(A) Domains of human TNKS and TNKS2. (B) Activation of β-catenin/TCF/LEF-dependent 
transcription by MYC2-Tankyrases in unstimulated HEK293T cells, assayed by TOPFlash and 
control FOPFlash reporters. Data are expressed relative to mean reporter activities obtained without 
MYC2 construct (7 samples in set). n=3 duplicate experiments; error bars, SEM. (C) Transcription 
reporter assay as in (B), using 16 ng of MYC2-Tankyrase constructs. “Fold activation” is relative to 
vector only. n=6 duplicate experiments; error bars, SEM. (D) Transcription reporter assay as in (C). 
Cells were treated with 9.8 nM to 10 µM of XAV939, in a two-fold dilution series. Data are 
expressed relative to reporter activity in the “vector” control in the absence of XAV939. n=3 
duplicate experiments; error bars, SEM. See Figure S2A for TNKS2 PARylation assessment. (E) 
Transcription reporter assay as in (C). n=3 duplicate experiments; error bars, SEM. See Figure S1 
for Tankyrase expression levels in luciferase reporter assays. (F) In-vitro PARylation assay for the 
indicated immunoprecipitated MYC2-tagged Tankyrases. Top, Western blot analysis of 
immunoprecipitates; bottom, autoradiograph. 
 
Figure 2: Polymerisation of the TNKS and TNKS2 SAM domains 
(A) Ultracentrifugation sedimentation assay. Purified SAM domains (25 µM) were centrifuged and 
total samples (T), supernatants (S) and pellets (P) analysed by SDS-PAGE and Coomassie staining. 
The diagram illustrates the assay principle. (B) EM of SAM domains at the indicated 
concentrations. Scale bars, 50 nm. (C) SEC-MALS. Chromatograms show one experiment with 
differential refractive index (dRI), light scattering (LS) and calculated molecular weight per slice i 
(Mi). Weight-average molecular weights (Mw) and dispersity (Đ) ±SD over peaks are indicated. See 
Figures S3B and C for eluate analyses by SDS-PAGE. The atypically delayed elution of the long 
TNKS2 SAM filaments likely reflects an interaction/entanglement with the column solid phase. 
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Scatter plots combine data from two experiments with Mw, Đ and associated SD indicated. Plotted 
data points with mean and error bars (SD) refer to Mi. See Figure S2 for further data. 
 
Figure 3: Crystal structure of the TNKS2 SAM domain 
(A) Structure of the TNKS2 DH902/924RET2 SAM domain filament. (B) A pair of “wild-type 
rendered” TNKS2 SAM domains from the filament, coloured by Coulombic surface electrostatic 
potential. (C) Ultracentrifugation sedimentation assay as for Figure 2A at increasing [NaCl]. (D) 
Detailed representation of a TNKS2 DH902/924RET2 SAM domain pair. Interface residues in stick 
representation with orange lines indicating contacts. Mutations required for crystallisation are 
indicated. 
 
Figure 4: Crystal structures of the TNKS SAM domain and comparison with TNKS2 
(A) and (B) TNKS D1055RT1 SAM domain filaments. Subscript numbers of chain identifiers 
denote the corresponding asymmetric units. See Figure S4 for a contact analysis. (C) EH-presenting 
SAM domains from unique SAM domain pairs were superimposed over residues 1030-1068T1/877-
933T2 and average Cα RMSD values for both protomers calculated. (D) Multiple sequence 
alignment of SAM domains from representative Tankyrase orthologues. Circles denote interface 
residues (by solvent-inaccessibility); filled circles indicate explicit contacts in crystal structures. 
“X” denotes mutated residues. See Extended Experimental Procedures for sequence accession 
numbers. (E) Conservation of the SAM-SAM interface. Top, interface residues observed in any of 
the crystal structures in green; bottom, residues identical in ≥80% of the orthologues shown in (D) 
in red. 
 
Figure 5: Characterisation of Tankyrase SAM domain mutants 
(A) Ultracentrifugation sedimentation assays as for Figure 2A. Colour coding indicates the degree 
of abrogated sedimentation. H924T2, K928T2 and E906T2 charge reversals were more severe than 
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changes to alanine. (B) SEC-MALS of Tankyrase SAM domains, as in Figure 2C (Mw±SD, n=2). 
Colour coding as in (A). TNKS2 WT reference data, from the same experiment, are identical to 
Figure 2C. See Figure S3B for eluate analyses by SDS-PAGE and Figures S5A and B for CD 
spectroscopy. (C) EM of TNKS2 SAM domains. Scale bars, 50 nm. See Figure S3F for further 
mutants. Colour coding as in (A). (D) ITC analysis for the indicated SAM domain pairs. Mutated 
surfaces are indicated by the star in the schematics. See Figure S5C for a second experiment. 
 
Figure 6: Tankyrase requires polymerisation to drive Wnt-β-catenin signalling 
(A) Homo- and heterotypic interactions of TNKS and TNKS2 in HEK293T cells. FLAG3-
Tankyrases were immunoprecipitated and co-precipitation of MYC2-Tankyrases assessed by SDS-
PAGE and Western blotting. TNKS2 expression is lower than TNKS, accounting for the weaker 
apparent TNKS2 self-association (Figure S1E). See Figure S6A and B for cell lysate fractionations 
and additional co-immunoprecipitations. (B) Tankyrase polymerisation controls localisation. 
Serum-starved HeLa cells expressing the indicated mCherry- and mCitrine-tagged Tankyrases were 
vehicle- or XAV939-treated. See Figure S6C and D for controls and additional experiments. Scale 
bar, 10 µm. (C) and (D) Tankyrase polymerisation controls Wnt-β-catenin signalling. Transcription 
reporter assays for selected TNKS2 and TNKS SAM domain mutants, as for Figure 1C. Reporter 
activity was normalised to wild-type TNKS2 or TNKS (100%). Colour coding reflects 
polymerisation defects of the corresponding SAM domains as assessed by sedimentation, SEC-
MALS and EM (see Figure 5). n=3 duplicate experiments; error bars, SEM. See Figure S1 for 
expression levels and Figure S7 for further data. 
 
Figure 7: Tankyrase polymerisation supports PARP activity and interaction with AXIN. 
(A) In-vitro PARylation by immunoprecipitated MYC2-TNKS2. Top, autoradiograph with 
quantitation; middle, corresponding Coomassie-stained SDS-PAGE gel; bottom, Western blot 
analysis of immunoprecipitates prior to in-vitro PARylation. (B) PAR was released from samples 
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analysed in (A) and equal amounts of PAR, or all available sample for ‘vector’ and ‘TNKS2 
G1032W’, analysed by PAGE and autoradiography. Origin (O) and PAR chain length are indicated. 
(C) SW480 cells expressing the indicated MYC2-tagged TNKS2 constructs were XAV939-treated, 
fixed and stained for MYC2-TNKS2, endogenous AXIN2 and DNA. Yellow arrows denote 
degradasomes with AXIN2-TNKS2 colocalisation; red arrows denote degradasomes containing 
AXIN2 but not TNKS2. Scale bar, 10 µm. (D) Endogenous AXIN1 was immunoprecipitated from 
HEK293T cells expressing the indicated MYC2-TNKS2 constructs. Samples were analysed by 
SDS-PAGE and Western blotting. (E) A model for the role of polymers and multivalency in the 
Tankyrase-AXIN system; see Discussion for details. Red arrows, interactions; black arrow, 
regulation. 
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Table 1: Data collection and refinement statistics 	
Data Collection 1 TNKS2 SAM DH902/924RE TNKS SAM D1055R TNKS SAM D1055R 
crystal form 1 crystal form 2 
(5 datasets/3 crystals) (2 datasets/2 crystals) 
PDB ID 5JRT  5JU5 5JTI 
Beamline Diamond I03 Diamond I03 Diamond I03 
Wavelength (Å) 0.976 0.976 0.976 
Space group P65 P21 P21 
Unit cell       
a, b, c (Å) 56.63, 56.63, 46.11 52.24, 55.22, 83.05 70.93, 55.48, 79.41 
α, β, γ (°) 90, 90, 120 90, 96.2, 90 90, 102.9, 90 
Molecules/ASU 1 6 6 
Resolution (Å) 28.32-1.53 (1.56-1.53) 82.57-2.5(2.6-2.5) 77.41-2.9 (3.0-2.9) 
Total number of reflections 207561 (10406) 454569 (51435) 87050 (13527) 
Number of unique reflections 12797 (618) 16511 (1870) 13604 (2185) 
Rmerge 2 0.058 (2.932) 0.406 (5.731)  2.297 (6.557) 
Rmeas 2 0.061 (3.120) 0.422 (6.002) 2.525 (7.589) 
Mean I/σI 20.5 (0.9) 11.2 (1.3) 9.6 (1.4) 
CC1/2 3 0.999 (0.408) 0.997 (0.333) 0.892 (0.35) 
 CC:d1   0.996 (0.030) 0.969 (0.494) 
 CC:d2   0.998 (0.713) 0.817 (0.256) 
 CC:d12 0.99 (0.323)     
 CC:d3 0.99 (0.480) 0.999 (0.683) 0.973 (0.678) 
Completeness (%) 100 (100) 100 (100) 100 (100) 
Multiplicity 16.2 (16.7) 27.5 (27.5) 6.6 (6.5) 
Wilson B factor (Å2) 37.69 34.51 18.57 
Refinement 1       
Resolution (Å) 28.32 - 1.53 82.57 - 2.5 77.41 - 2.9 
Rwork/Rfree (test set 5%) 0.201/0.233 0.191/0.211 0.193/0.232 
Reflections used in refinement 12770 16498 13593 
Reflections in Rfree test set 636 802 681 
RMSD bond lengths (Å) 0.01 0.01 0.01 
RMSD bond angles (°) 0.94 1.13 1.19 
Number of protein atoms 510 2855 2854 
Number of solvent atoms 40 24 62 
B factor protein (Å2) 46.71 65.21 53.1 
B factor solvent (Å2) 50.92 52.81 36.54 
Ramachandran favoured (%) 100 99 96.5 
Ramachandran allowed (%) 0 1 3.5 
Ramachandran disallowed (%) 0 0 0 
1 Values for the highest-resolution shell are shown in parentheses. 
2 Rmerge and Rmeas as calculated in AIMLESS (Winn et al., 2011). High Rmerge and Rmeas are attributable to the high-
resolution cut-off (Karplus and Diederichs, 2012) and anisotropy (see footnote 3). 
3 The principal directions of anisotropy as defined by symmetry (axes or planes), as analysed in AIMLESS (Winn et al., 
2011). For TNKS SAM crystal form 1, the anisotropy is pronounced along CC_d1 (along 0.91 h – 0.40 l), with CC1/2 
falling below 0.30 at 3.0 Å.  
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Supplemental Figure Legends 
 
Figure S1: Protein expression levels in luciferase reporter assays and immunoprecipitation, 
related to Figures 1 and 6 
(A) to (D), (F), (G) HEK293T cells were transiently transfected in technical triplicate for luciferase 
reporter assays. Two replicates were assessed for luciferase activity (see main figures). A third 
replicate was analysed by SDS-PAGE and Western blotting as indicated to assess protein 
expression levels. The dashed line in (F) separates lanes from two different gels/membranes. (E) 
The same INPUT samples shown in the first two lanes of each of the three panels of Figure 6A 
were analysed by SDS-PAGE and Western blotting on the same gel and membrane for direct 
comparison, as indicated. MYC2-TNKS is consistently more highly expressed than MYC2-TNKS2. 
 
Figure S2: Tankyrase modulation by enzymatic inhibition, AXIN1 and the SAM domain, 
related to Figures 1 and 2 
(A) HEK293T cells were transfected with MYC2-TNKS2 and treated with the same concentrations 
of XAV939 as for Figure 1D for 20 h. MYC2-TNKS2 was immunoprecipitated and 
immunoprecipitates analysed for PAR by Western blotting as indicated. (B) TOPFlash transcription 
reporter assay. MYC2-TNKS2, TNKS2 G1032WT2 or empty vector (16 ng) were co-expressed with 
increasing amounts of the indicated FLAG3-AXIN1 constructs (0.6 to 20 ng in a two-fold dilution 
series), either in wild-type form or as Tankyrase-binding deficient mutant (GG27/74RR, GG-RR). 
Data are expressed relative to the mean reporter activity in the “vector” control without AXIN1. 
n=3 independent experiments done in technical duplicate; error bars, SEM. Western blots to assess 
protein expression levels in the assay are shown below. Note that at the highest dose of AXIN1 
construct, TNKS2 expression is reduced, accounting for the loss in reporter activation at this dose. 
(C) Ultracentrifugation sedimentation assay as in Figure 2A. (D) Electron microscopy analysis of 
negatively stained Tankyrase SAM domains at 0.025 mM. See Figure S3A for SEC-MALS 
analysis. (E) TOPFlash transcription reporter assay as in Figure 1C, using 16 ng of MYC2-TNKS2 
constructs. n=3 to 6 independent experiments done in technical duplicate; error bars, SEM. 
Tankyrase expression levels in the assay are shown below. 
 
Figure S3: SEC-MALS and EM of Tankyrase SAM domains, related to Figures 2 and 5 
(A) and (D) Molecular weight scatter plots from two separate SEC-MALS analyses for the 
indicated SAM domains at 0.5 mM (A) and 1 mM in total (0.5 + 0.5 mM for paired mutant 
domains) (D). Weight-average molecular weights (Mw) and dispersity (Đ) ±SD are indicated. 
Plotted data points with mean and SD refer to single molecular weight data points (Mi) 
corresponding to measurement slices. SEC-MALS for V90WT2 + Y920AT2 and V1056WT1 + 
Y920AT2 TNKS2, shown in (D), also revealed monomeric sub-populations (grey data points). Mw 
and Đ shown for these samples refer to the dimeric sub-population. TNKS2 WT reference data are 
the same as shown in Figures 2C and 5B (acquired as part of the same sample set). Likewise, TNKS 
WT reference data are the same as shown in Figure 5B; TNKS SAM T1049RT1 data were acquired 
as part of the same sample set. See below ((B) and (E)) for an analysis of the corresponding elution 
fractions. See Figures S5A and B for quality control of purified mutant proteins by CD 
spectroscopy. (B), (C), (E) Samples from SEC-MALS elution fractions (10 µl) were analysed by 
SDS-PAGE and Coomassie Brilliant Blue staining. Void volume (V0) and salt peak volume are 
indicated where corresponding fractions were analysed. i, input (1 µl). Input protein concentration 
and column are indicated. The dashed line in (C) separates lanes from two different gels. (F) 
Electron microscopy analysis of the indicated TNKS2 SAM domains at 25 µM and 100 µM. Scale 
bars, 50 nm. Colour coding indicates the degree of abrogated sedimentation, as in Figure 5. 
 
Figure S4: TNKS SAM domain packing and comparative analysis of SAM-SAM contacts in 
the TNKS and TNKS2 SAM domain crystal structures, related to Figure 4 
Non-crystallographic and crystallographic symmetry in two TNKS D1055RT1 SAM domain crystal 
forms gives rise to filaments in the crystals. (A) Crystal form 1. (B) Crystal form 2. In both cases, 
the asymmetric unit consists of six SAM domains, but the two asymmetric units are distinct from 
each other. Left, four adjacent asymmetric units are shown in ribbon representation with one 
filament in side view highlighted by higher opacity. The six chains within the left-most asymmetric 
unit are named A1 to F1. Subscript numbers of chain identifiers denote the corresponding 
asymmetric units (1-4). A repeating unit in the filament consists of six protomers. Right, the same 
assembly rotated by 90° along the y axis reveals the approximate six-fold symmetry. Centroids for 
each SAM domain in the repeating unit, depicted as spheres, were calculated for TNKS SAM 
residues 1030-1087. Approximate angles between the centroids of each SAM domain in the axial 
projection were measured, using the overall centroid of all six centroids as vertex. (C) Contact 
analysis for all SAM-SAM domain pairs observed in all three crystal structures, analysed in UCSF 
Chimera. SAM-SAM domain pairs are numbered as indicated in the table on the right. A coloured 
field (TNKS crystal form 1, orange; TNKS crystal form 2, pale orange; TNKS2, blue) represents 
the occurrence of the respective contact. 
 
Figure S5: CD spectroscopy analysis of purified TNKS and TNKS2 SAM domains and a 
second ITC experiment, related to Figure 5 
(A) and (B) Purified proteins at 0.2 mg/ml were analysed by CD spectroscopy. The calculated 
helical contents of the TNKS and TNKS2 SAM domains from the crystal structures is 61%. 
Measured helical contents are comparable, with the exception of strongly polymerising SAM 
domains (TNKS2 SAM and TNKS SAM T1049RT1, denoted by asterisks), where helical contents 
appear underestimated. Reduced molar ellipticities were previously observed for a polymerising C-
terminal truncation of serum amyloid A (SSA), and absorption flattening due to a changed protein 
environment in the polymer was proposed to account for this effect (Patke et al., 2012). The 
observation that SAM domains with mutations in opposite interfaces are still able to form dimers 
(see Figures S3D and E) provides additional documentation for their correct folding. (C) Replicate 
isothermal titration calorimetry (ITC) experiment as in Figure 5D. 
 
Figure S6: Assessment of TNKS and TNKS2 polymerisation by biochemical assays and 
microscopy, related to Figure 6 
(A) Full-length TNKS and TNKS2 polymerise in a SAM-domain dependent manner. Lysates from 
cells expressing the indicated MYC2-Tankyrase constructs were fractionated by size exclusion 
chromatography. Fractions were analysed by Western blotting as indicated. Dashed lines separate 
lanes from two different gels/membranes. (B) The T1049RT1 and R896T2 mutations do not appear to 
affect Tankyrase self-interaction in the context of the full-length protein, at least under the 
experimental conditions. The indicated FLAG3- and MYC2-tagged TNKS and TNKS2 constructs 
were co-expressed in HEK293T cells and FLAG3-Tankyrases immunoprecipitated, as for Figure 
6A. Lysates and immunoprecipitates were analysed by SDS-PAGE and Western blotting as 
indicated. (C) Tankyrase polymerisation controls localisation. Serum-starved HeLa cells expressing 
the indicated mCherry- and mCitrine-tagged Tankyrase constructs were vehicle- or XAV939-
treated as indicated, fixed and imaged by fluorescence microscopy. Microscopy data were obtained 
together with those shown in Figure 6B. Scale bar, 10 µm. (D) TNKS and TNKS2 colocalise. 
Microscopy was performed as for (C). Scale bar, 10 µm. 
 
Figure S7: Polymerisation requirement of TNKS2 to drive Wnt-β-catenin signalling, related to 
Figure 6 
(A) Co-expression of TNKS2 V903WT2 and Y920AT2, which would be able to form dimers (see 
Figures S3D and E), does not rescue the lost ability of the individual mutants to induce Wnt 
signalling. TOPFlash transcription reporter assays for the indicated pairs of TNKS2 SAM domain 
mutant derivatives, performed as for Figure 1C. The total amount of MYC2-TNKS2 construct per 
transfection was 16 ng (8 ng + 8 ng for paired TNKS2 mutants). n=3 independent experiments done 
in technical duplicate; error bars, SEM. Western blots to assess TNKS2 expression levels in the 
assay are shown below. The schematic on the right illustrates the formation of heterodimers 
between ML and EH mutant derivatives, which are monomeric on their own, as shown by SEC-
MALS (see Figure S3D and E). Although unlikely, we cannot rule out that SAM-SAM interactions 
within the dimer are weakened by the distal mutations. (B)-(E) Polymerisation of an orthologous 
SAM domain partially compensates for loss of the SAM domain in TNKS2. The dashed line in the 
Western blot shown in (E) indicates the position where an irrelevant lane has been spliced out. (B) 
Top, schematic representation of chimeric TNKS2 construct with the SAM domain of D. 
melanogaster Polyhomeotic (Ph). Bottom, structure-based alignment of the SAM domains of H. 
sapiens TNKS2 (DH902/924RET2) and D. melanogaster Ph (L1547R). Amino acids shown in grey 
are not resolved in the crystal structures. Mutations introduced for crystallization are indicated in 
red. Interface residues, as identified by PISA and defined through limited solvent accessibility, and 
explicit contact residues, as analysed in UCFS Chimera, are indicated by open and closed circles, 
respectively, as in Figure 4D. For the TNKS2 Ph SAM chimera, TNKS2 residues 876-936 were 
replaced by Ph residues 1504-1577, as indicated. (C) Electron micrograph of negatively stained D. 
melanogaster Ph SAM domain polymers. Scale bar, 50 nm. (D) Structural representations of the 
superimposed TNKS2 and D. melanogaster Ph SAM domains (PDB accession code: 1KW4). A 
L1561R mutation results in loss of Ph SAM domain polymerisation (Kim et al., 2002). (D) 
TOPFlash transcription reporter assay as in Figure 1C. n=6 independent experiments done in 
technical duplicate; error bars, SEM. Western blots to assess Tankyrase expression levels in the 
assay are shown below. The Ph SAM domain conferred a weak activation of the transcription 
reporter by TNKS2, illustrating incomplete rescue, but this was abolished by a validated, structure-
based polymer-breaking mutation in the heterologous domain (Kim et al., 2002). Note the log 2 
scale. 
  
Supplemental Tables 
Table S1. Plasmids used in this study, related to Experimental Procedures 
Point mutations and deletions were generated from these plasmids by site-directed mutagenesis (see 
section “Plasmids” in Extended Experimental Procedures). 
 
plasmid name species accession 
no. 
sites references/information 
bacterial expression constructs 
pET-His6-MBP-Asn10-TEV (1C)-
TNKS(1018-1093) 
H. sapiens NM_003747.2 LIC v1 1 
pET-His6-MBP-Asn10-TEV (1C)-
TNKS2(867-940) 
H. sapiens NM_025235.2 LIC v1 1 
pET-His6-MBP-Asn10-TEV (1C)-
Ph(1502-1587) 
 
D. 
melanogaster 
NM_057523.5 LIC v1 1, 2 
mammalian expression constructs / reporter plasmids / vectors 
pLP-dMYC SD-TNKS H. sapiens NM_003747.2 AscI-PacI & loxP 3, 4 
pLP-dMYC SD-TNKS2 H. sapiens NM_025235.2 AscI-PacI & loxP 4, 5 
pLP-tripleFLAG SD-TNKS H. sapiens NM_003747.2 AscI-PacI & loxP 4 
pLP-tripleFLAG SD-TNKS2 H. sapiens NM_025235.2 AscI-PacI & loxP 4 
pLP-mCitrine C1 SD-TNKS H. sapiens NM_003747.2 AscI-PacI & loxP 4, 6 
pLP-mCitrine C1 SD-TNKS2 H. sapiens NM_025235.2 AscI-PacI & loxP 4, 6 
pLP-mCherry C1 SD-TNKS H. sapiens NM_003747.2 AscI-PacI & loxP 4, 6 
pLP-mCherry C1 SD-TNKS2 H. sapiens NM_025235.2 AscI-PacI & loxP 4, 6 
pLP-tripleFLAG SD-AXIN1 H. sapiens NM_003502.3 AscI-PacI & loxP 4, 7 
M50 Super 8x TOPFlash - - - 8 
M51 Super 8x FOPFlash 
(TOPFlash mutant) 
- - - 8 
ptkRL - - - 9 
pDNR-MCS SA - - - 4 
 
1 The empty vector was a gift from Dr. Scott Gradia (UC Berkeley) via Addgene (Addgene plasmid # 29654) 
2 The Ph cDNA was a gift from Dr. Robert Kingston (Harvard Medical School) via Addgene (Addgene plasmid # 1925) 
(Francis et al., 2001) 
3 The pLP-dMyc SD-TNKS plasmid was a kind gift from Dr. Robert Rottapel (OCI, Toronto). 
4 (Colwill et al., 2006) 
5 (Guettler et al., 2011) 
6 The pLP-Citrine C1 SD and pLP-mCherry C1 SD plasmids were a kind gift from Dr. Oliver Rocks (MDC, Berlin). 
7 The AXIN1 cDNA (OriGene) was a kind gift from Dr. Alan Ashworth and Dr. Chris Lord (ICR, London). 
8 M50 Super 8x TOPFlash and M51 Super 8x FOPFlash (TOPFlash mutant) were a gift from Randall Moon (Addgene 
plasmid # 12456) (Veeman et al., 2003) 
9 ptkRL, originally from Promega, was a kind gift from Dr. Richard Treisman (Francis Crick Institute, London). 
  
Extended Experimental Procedures 
Plasmids 
Plasmids (see Table S1) were generated from human Tankyrase (TNKS, NM_003747.2), 
Tankyrase 2 (TNKS2, NM_025235.3), AXIN1 (NM_003502.3) and D. melanogaster Ph 
(NM_057523.5) cDNAs by standard recombinant DNA techniques involving, PCR, restriction 
endonucleases and ligation-independent cloning (Li and Elledge, 2007). For full-length mammalian 
expression constructs, the initiator methionine codon was omitted. PCRs, including those for site-
directed mutagenesis, were performed using KAPA HiFi HotStart DNA polymerase (KAPA 
Biosystems). Site-directed point and deletion mutant derivatives and chimeric constructs were 
obtained using either a modified QuikChange protocol (Agilent Technologies), a two-step 
megaprimer method or overlap extension. SAM domain deletions in TNKS and TNKS2 
encompassed the equivalent regions in both proteins: TNKSΔSAM (Δ1026-1091), TNKS2 ΔSAM 
(Δ873-938). TNKS2 ΔARC1-5 lacks amino acids 23-794. The TNKS2 xx3xx (L92W, L245W, 
L560W, L713W) construct was reported previously (Guettler et al., 2011). In the TNKS/TNKS2 
SAM domain chimeras, residues 1025-1093T1 and 873-940T2, which span the variable range within 
the SAM domains of TNKS and TNKS2, were mutually exchanged. The TNKS2 Ph SAM chimera 
was generated by replacing TNKS2 residues 876-936 by Ph residues 1504-1577 (numbering for D. 
melanogaster ph-p, transcript variant A, NM_057523.5). Two Tankyrase-binding motifs were 
mutated in AXIN1 GG-RR (GG27/74RR). All other mutant derivatives are named by the respective 
mutation. All constructs were sequence-verified. 
 
Antibodies and compounds 
Antibodies were anti-MYC 9E10 (MA1-81358, Thermo Fisher Scientific), anti-FLAG 
FG4R (MA1-91878, Thermo Fisher Scientific), anti-FLAG M2 (F3165, Sigma), anti-AXIN1 
C76H11 (2087S, Cell Signaling Technology), anti-AXIN2 (76G6, Cell Signaling Technology), 
anti-PAR (rabbit polyclonal, Trevigen), anti-TNKS1/2 (H-350, sc-8337, Santa Cruz Biotechnology) 
and control IgG (sc-2027, Santa Cruz Biotechnology). Secondary antibodies for Western blotting 
with detection using an Odyssey infrared imaging system (LI-COR) were goat-anti-mouse-
DyLight680 (35518, Thermo Fisher Scientific), goat-anti-rabbit-DyLight800 (35571, Thermo 
Fisher Scientific), IRDye 800CW donkey anti-mouse (926-32212, LI-COR) and IRDye 800CW 
donkey anti-rabbit (926-32213, LI-COR). Secondary antibodies for Western blotting with ECL 
detection were goat-anti-mouse-HRP (32430, Thermo Fisher Scientific) and goat-anti-rabbit-HRP 
(32460, Thermo Fisher Scientific). Secondary antibodies for immunofluorescence microscopy were 
goat-anti-mouse-DyLight488 (35502, Thermo Fisher Scientific) and goat-anti-rabbit-DyLight633 
(35562, Thermo Fisher Scientific). XAV939 was obtained from Dr. Chris Lord (ICR). 
 
Mammalian cell culture 
HEK293T and SW480 cells, obtained from Dr. Chris Lord (ICR, London), and HeLa cells, 
obtained from Dr. Chris Bakal (ICR, London), were cultured in a humidified incubator at 37 °C 
with 5% CO2 in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with antibiotics 
(streptomycin sulfate, benzylpenicillin) and 10% FBS (F7524, Sigma). Cells were serum-starved 
(0.3% FBS) where indicated. 
 
Luciferase reporter assays 
The TOPFlash reporter construct contains six TCF/LEF transcription factor binding sites 
and responds to active β-catenin (Veeman et al., 2003). On day one, HEK293T cells were plated on 
white 96-well plates (30,000 cells/well). On day two, cells were transfected, in technical triplicate, 
with the indicated vector (pLP-dMYC SD, pLP-tripleFLAG SD), Tankyrase constructs in pLP-
dMYC SD (16 ng/well or as indicated) or the specified amounts of AXIN1 constructs in pLP-
tripleFLAG SD, 10 ng/well TOPFlash or FOPFlash, and 2 ng/well ptkRL. DNA was filled up to a 
total amount of 50 ng/well using pDNR-MCS SA. Cell media were changed for 100 µl Opti-MEM 
II (Thermo Fisher Scientific / Gibco) and cells were transfected using Lipofectamine 2000 (Thermo 
Fisher Scientific / Invitrogen) in a DNA:transfectant ratio of 1:3 in Opti-MEM II. Four hours after 
complex addition, media were changed for DMEM with 0.3% FBS. XAV939 was added in a two-
fold dilution series from 9.8 nM to 10 µM at the media change step, maintaining a constant DMSO 
concentration of 0.2%. Twenty hours after media change, cells from two technical replicates were 
lysed using Passive Lysis Buffer (Promega) and processed for luminometry using the Dual-
Luciferase Reporter Assay system (Promega). Plates were read using a Perkin Elmer VICTOR X5 
plate reader using an integration time of 5 s. Upon background subtraction, ratios of Firefly 
Luciferase to Renilla Luciferase signals were calculated for each of the two technical replicates. 
The means of the technical replicates were further analysed as indicated in the figure legends. Data 
shown are from at least three independent experiments performed in technical duplicate, as detailed 
in the figure legends. A third technical replicate was processed for analysis by SDS-PAGE and 
Western blotting to assess protein levels (see Figure S1). 
 
Expression and purification of TNKS and TNKS2 SAM domains for crystallisation, electron 
microscopy, multi-angle light scattering, circular dichroism spectroscopy and isothermal 
titration calorimetry 
Human TNKS SAM (1018-1093) and TNKS2 SAM (867-940) domain constructs were 
expressed as His6-MBP-Asn10 fusion proteins in E. coli BL21-CodonPlus(DE3)-RIL (Stratagene) 
grown in TB media. Expression was induced at an OD600 of 2.0 with 0.5 mM IPTG overnight at 18 
°C. Cells were collected by centrifugation, resuspended in a buffer containing 50 mM Tris-HCl (pH 
7.5), 1.5 M NaCl (high to limit SAM domain polymerisation), 5 mM imidazole (pH 7.5), 10 mM β-
mercaptoethanol and protease inhibitors (1 mM PMSF, 1 µg/ml leupeptin, 1 µg/ml aprotinin, 1 
µg/ml pepstatin A) (pellet from 1 l of culture resuspended in 50 ml buffer), lysed by 
homogenisation using an EmulsiFlex-C5 homogenizer (Avestin) or by sonication using a Vibra-
Cell sonicator (Sonics & Materials) and centrifuged to remove insoluble material. Lysates were 
briefly sonicated to shear E. coli genomic DNA and filtered through a 0.45 µm filter. Filtered 
lysates were loaded onto 5 ml Ni HisTrap HP affinity columns (GE Healthcare). Columns were 
washed with at least 5 column volumes (CV) of wash buffer (identical to lysis buffer but lacking 
protease inhibitors). His6-MBP fusion proteins were eluted with a linear imidazole gradient (5 to 
250 mM imidazole, pH 7.5) in a buffer also containing 50 mM Tris-HCl (pH 7.5), 1.5 M NaCl and 
reducing agent. To remove the His6-MBP tag, the fusion proteins were incubated with recombinant 
TEV protease overnight while dialysing against 50 mM Tris-HCl (pH 7.5), 200 mM NaCl (1.5 M 
NaCl for TNKS SAM T1049R and TNKS2 SAM), 10 mM β-mercaptoethanol. The His6-MBP-
Asn10 tag was removed by another Ni affinity chromatography step using a 5 ml Ni HisTrap HP 
affinity column (GE Healthcare), with the exception of TNKS SAM T1049R and TNKS2 SAM 
which were diluted 10 fold and incubated for ≈48 hrs with 25 ml HisPur Ni-NTA Superflow 
Agarose (Thermo Fisher Scientific) to efficiently remove the His6-MBP tag entrapped by the 
polymerising proteins and further dialysed against 50 mM Tris-HCl (pH 7.5), 200 mM NaCl, 10 
mM β-mercaptoethanol. All proteins were applied onto 5-ml HisTrap Q HP columns (GE 
Healthcare) for ion-exchange chromatography. The proteins were eluted in a linear NaCl gradient 
(0.2 to 1 M NaCl) in a buffer also containing 50 mM Tris-HCl (pH 7.5) and 10 mM β-
mercaptoethanol. The resulting protein was dialysed against 25 mM HEPES-NaOH (pH 7.5), 1.5 M 
NaCl, 10 mM β-mercaptoethanol, concentrated and subjected to size-exclusion chromatography on 
a 120-ml HiLoad 16/60 Superdex 75 (prep grade, GE Healthcare) equilibrated in 25 mM HEPES-
NaOH (pH 7.5), 1.5 M NaCl, 2 mM TCEP. Pure fractions were pooled, concentrated and flash-
frozen in liquid nitrogen. D. melanogaster Ph SAM domain (1502-1587) was purified as 
TNKS/TNKS2 SAM, but instead of 1.5 M NaCl, only 500 mM NaCl were used. Before 
experiments, proteins were dialysed against 25 mM HEPES-NaOH (pH 7.5), 200 mM NaCl, 2 mM 
TCEP overnight to lower the NaCl concentration kept high to limit polymer formation during 
purification. Proteins were quantified spectrophotometrically, using extinction coefficients 
calculated by ExPASy ProtParam (Gasteiger et al., 2005), and by amino acid analysis (Protein & 
Nucleic Acid Chemistry Facility, Department of Biochemistry, University of Cambridge, UK). 
Given that the Tankyrase SAM domains only contain a single aromatic residue enabling A280 
measurements, spectrophotometrically measured SAM domain concentrations were corrected by a 
calibration factor based on amino acid analysis performed earlier. 
 
Protein crystallisation 
Initial crystal hits of TNKS2(867-940) DH902/924RET2 obtained from the Index HT sparse-
matrix screen (Hampton Research) were optimised by mixing 1 µl of a 13.5 mg/ml protein solution 
(in 25 mM HEPES-NaOH (pH 7.5), 100 or 200 mM NaCl, 2 mM TCEP) with 1 µl of a precipitant 
solution containing 0.1 M Tris-HCl pH 8.5, 0.2 M ammonium acetate, 20% PEG 3350 in a 
hanging-drop vapour-diffusion setup at 12 °C, using a 24-well setup and 1 ml of precipitant solution 
in the wells. Streak seeding with horse tail hair (Nenê) was performed one day after setting up 
crystallisation trays with seeds from crystals obtained earlier. Crystals grew within 2 days upon 
seeding. Before flash-freezing in liquid nitrogen, crystals were cryo-protected in a stabilisation 
solution identical to the precipitant solution but also containing 30% PEG 400. 
Crystals for TNKS SAM (1018-1093) D1055RT1 were grown by sitting-drop vapour diffusion 
at 12 °C using the Index HT (Hampton Research) sparse matrix screen by mixing 150 nl of protein 
solution at 10 mg/ml (in 25 mM HEPES-NaOH (pH 7.5), 200 mM NaCl, 2 mM TCEP) with 150 nl 
of a precipitant solution containing 0.2 M MgCl2, 0.1 M Bis-Tris pH 5.5, 25% PEG 3350. Crystals 
grew within 3 weeks. Before flash-freezing in liquid nitrogen, crystals were cryo-protected in a 
stabilisation solution identical to the precipitant solution but also containing 25% ethylene glycol. 
 
Data collection, structure determination and structure analyses 
Diffraction data for TNKS2 SAM DH902/924RET2 were collected at the Diamond Light 
Source on beamline IO3. Data were processed and scaled using XDS (Kabsch, 2010) and merged 
using AIMLESS (Winn et al., 2011). The structure was solved by molecular replacement using 
Phaser (Adams et al., 2010; McCoy et al., 2007) with a homology model generated by 
Modeller/HHPred (Šali et al., 1995) based on 5 templates (PDB codes: 1v85_A, 3bs5_B, 3bq7_A, 
2e8o_A, 2gle_A) as a search model. The structure model was generated iteratively by manual 
model building in Coot (Emsley et al., 2010) and refinement using Phenix Refine (Adams et al., 
2010) and BUSTER (Bricogne et al., 2016). 
Diffraction data for two crystal forms obtained for TNKS SAM D1055RT1 were collected at 
the Diamond light source on beamline IO3, processed using XDS (Kabsch, 2010) and scaled using 
AIMLESS (Collaborative Computational Project, 1994). For TNKS SAM crystal form 1, five 
datasets from a total of three crystals were analysed using BLEND (Foadi et al., 2013) giving a 
Linear Cell Variation of 0.7 Å. BLEND was subsequently run in synthesis mode on all datasets and 
merging statistics indicated a high data resolution cutoff of 2.5 Å in order to achieve a half-dataset 
correlation coefficient CC(1/2) of 0.3 (Karplus and Diederichs, 2012). A second TNKS SAM 
crystal form was processed using merged data from two crystals as above. The structure was solved 
by molecular replacement in Phaser (Adams et al., 2010; McCoy et al., 2007) using a homology 
model for TNKS SAM D1055RT1, generated by SWISS-MODEL (Arnold et al., 2006), based on 
the crystal structure of TNKS2 SAM DH902/924RET2. The structure model was generated 
iteratively by manual model building in Coot (Emsley et al., 2010) and refinement using Phenix 
Refine (Adams et al., 2010) and BUSTER (Bricogne et al., 2016). High-resolution cut-offs were 
defined as described by Karplus and Diederichs (Karplus and Diederichs, 2012). During refinement, 
side chain atoms not accounted for by density due to residue mobility were removed. Structure 
coordinates and experimental structure factors have been deposited in the Protein Data Bank (PDB 
IDs 5JRT, 5JU5 and 5JTI). 
The structural representations were generated and structural analyses performed using UCSF 
Chimera (a product of the Resource for Biocomputing, Visualization, and Informatics at the 
University of California, San Francisco, supported by NIGMS P41-GM103311) (Pettersen et al., 
2004). For the electrostatics analysis shown in Figure 3B, the D902RT2 and H924ET2 mutations 
were reverted to wild-type; incompletely resolved side-chains were added in full, and the structure 
was energy-minimised using UCSF Chimera. Interface residues in SAM-SAM domain pairs for 
Figures 4D, 4E and S7B were identified using the PISA web server (Krissinel and Henrick, 2007). 
Head-to-tail SAM-SAM domain contacts were analysed using the ‘Find Clashes/Contacts’ function 
in UCSF Chimera (allowed overlap: -0.4 Å; H-bond overlap reduction: 0) (Pettersen et al., 2004). 
Note that PISA defines interface residues on the basis of (at least partial) solvent inaccessibility. 
Thus, not every interface residue will be involved in an explicit contact. 
 
Bioinformatics analyses 
 Sequences of Tankyrase orthologues used for the multiple sequence alignment in Figure 4D 
have the following NCBI accession numbers: NP_003738.2 (Homo sapiens), NP_780300.2 (Mus 
musculus), NP_989671.1 (Gallus gallus), XP_012428885.1 (Taeniopygia guttata), 
XP_004911090.1 (Xenopus tropicalis), XP_005451454.1 (Oreochromis niloticus), 
XP_003445711.1 (Oreochromis niloticus), NP_079511.1 (Homo sapiens), NP_001157107.1 (Mus 
musculus), NP_989672.1 (Gallus gallus), XP_012429997.1 (Taeniopygia guttata), 
NP_001017008.2 (Xenopus tropicalis), XP_005471626.1 (Oreochromis niloticus), XP_687410.4 
(Danio rerio), NP_001082884.1 (Danio rerio), NP_651410.1 (Drosophila melanogaster), 
XP_002121662.3 (Ciona intestinalis), XP_001897965.1 (Brugia malayi), XP_789260.3 
(Strongylocentrotus purpuratus), XP_005099438.1 (Aplysia californica), CDS23197.1 
(Echinococcus granulosus), XP_006825651.1 (Saccoglossus kowalevskii), XP_012563232.1 
(Hydra vulgaris), XP_011410275.1 (Amphimedon queenslandica). Clear TNKS and TNKS2 
orthologues seem to first appear in the fish Oreochromis niloticus, which has two TNKS-like 
Tankyrases and one TNKS2-like Tankyrase. Another fish species, Danio rerio, only appears to 
have two TNKS-like Tankyrases. Conservation-based and structure-based sequence alignments 
were generated using ClustalX (Larkin et al., 2007) and UCSF Chimera (Pettersen et al., 2004), 
respectively. Alignments, coloured by % identity, were visualised using Jalview (Waterhouse et al., 
2009). For Figure S7B, the SAM domain sequence of Drosophila melanogaster Polyhomeotic 
(NM_057523.5) was obtained from the SAM domain crystal structure (PDB accession code 1KW4) 
(Kim et al., 2002). 
 
Ultracentrifugation sedimentation assays 
SAM domains were purified as described above (see “Expression and Purification of TNKS 
and TNKS2 SAM Domains …”, for experiment shown in Figures 2A and S2C) or affinity-purified 
on a small scale using amylose resin (NEB) (for experiments shown in Figures 3C and 5A). 50 µl of 
a 25 µM solution (approximately 25 µM for experiments shown in Figures 3C and 5A) of SAM 
domains (in 25 mM HEPES-NaOH pH 7.5, 200 mM NaCl, 2 mM TCEP for Figure 2 and 50 mM 
Tris-HCl pH 7.5, 200 mM NaCl, 10 mM β-mercaptoethanol for Figures 3 and 5) were subjected to 
centrifugation at 200,000 x g (average speed) at 20 °C for 1 h in a TLA100 rotor (Beckman Optima 
TLX centrifuge). Supernatants were removed and pellets resuspended in 50 µl of SDS sample 
buffer. Equivalent amounts of total, supernatant and pellet samples were analysed by SDS-PAGE 
on Tris-Tricine gels and Coomassie Brilliant Blue staining. 
 
Circular dichroism spectroscopy 
Proteins at 0.2 mg/ml were dialysed into 10 mM Tris-HCl pH 7.5, 200 mM NaF. CD spectra 
were collected on a Jasco J-720 spectrometer using a 0.1 cm pathlength cell at the ISMB Biophysics 
Centre (London). Spectra were averaged over 5 scans and corrected for buffer baseline using 
CDtool (Lees et al., 2004). The analysis of the spectra was performed in DICHROWEB using the 
CDSSTR algorithm with SP175 as the reference set (Whitmore and Wallace, 2004; 2008). 
 
Electron microscopy 
3 µl of purified TNKS2 SAM domains at 25 µM or 100 µM and TNKS SAM domains at 25 
µM, 0.25 mM, 0.5 mM, 1 mM or 2 mM (in 25 mM HEPES-NaOH pH 7.5, 200 mM NaCl, 2 mM 
TCEP) were applied to glow-discharged carbon-coated grids and negatively stained with 2% (w/v) 
uranyl acetate. Electron micrographs were recorded at magnifications of either 11,000x (Figures 2 
and S2) or 42,000x (Figures 5 and S3) on an FEI Tecnai 12 electron microscope operating at an 
accelerating voltage of 120 kV, equipped with an F114 1k x 1k CCD detector (TVIPS, Germany). 
 
SEC-MALS 
20 µl of 0.5 mM, 1 mM or 2 mM protein samples were resolved by size exclusion 
chromatography on an Agilent Prostar HPLC system with a TSKgel G2000SWxl or G3000SWxl 
column (Tosoh Biocience LLC). Separation was performed in 25 mM HEPES-NaOH pH 7.5, 200 
mM NaCl, 2 mM TCEP at a flow rate of 1 ml/min. In-line light scattering was measured using 
DAWN Heleos-II light scattering instrument (Wyatt) and differential refractive index using an 
Optilab rEX instrument (Wyatt). Data analysis, using the Zimm light scattering model and a dn/dc 
of 0.185 ml/g, was performed using Wyatt’s ASTRA software. Weight-average molecular weights 
(Mw) and dispersities (Đ) with standard deviations were calculated for the elution peak areas in 
ASTRA. Two separate experiments were performed, and weighted averages of Mw and Đ and 
associated SD calculated. Weighting was performed by the number of data slices i. Plotted mean 
and error bars (SD) in scatter plots refer to molecular weights measured in individual slices (data 
points) Mi. Note that strongly polymerising SAM domains show a lower dRI signal, which is due to 
a more spread-out elution behaviour. The average SAM domain concentrations (from dRI 
measurements) in the selected peak areas for the wild-type SAM domain proteins analysed for 
Figure 2C were as follows: 0.5 mM TNKS SAM sample: 29 µM; 2 mM TNKS SAM sample: 108 
µM; 0.5 mM TNKS2 SAM sample: 10 µM. The surprisingly late elution of TNKS2 SAM may 
indicate an interaction or entanglement of the long polymers with the solid phase of the gel 
filtration column. An earlier elution peak close to the void volume did not contain any SAM domain 
(see Figure S3B). 
 
Isothermal titration calorimetry 
All proteins were dialysed in parallel into binding buffer containing 25 mM HEPES-NaOH 
pH 7.5, 200 mM NaCl, 1 mM TCEP. Titrations were carried out at 25 °C on an ITC200 
MicroCalorimeter (Microcal/GE Healthcare). TNKS2 SAM Y920AT2 or TNKS SAM Y1073AT1 at 
500 µM were serially injected in 2-µl increments into TNKS2 SAM V903WT2 or TNKS SAM 
V1056WT1 at 50 µM or buffer only. ITC data were processed using the Origin7 software 
(MicroCal). For all calculations, the signals obtained upon titrating injectant into buffer were 
subtracted. Integrated data were fitted using a one-site binding model. 
 
TNKS2 auto-PARylation assay and PAR analysis 
HEK293T cells were seeded on 15-cm cell culture dishes at 9 x 106 cells per dish. On the 
next day, cells were transfected with 30 µg per dish of pLP-dMYC SD empty vector or the 
indicated TNKS2 constructs (2 dishes per construct) using calcium phosphate. 24 h post-
transfection, cells were scraped in ice-cold PBS and cell pellets lysed in 1 ml high-salt RIPA buffer 
(50 mM HEPES-NaOH pH 7.5, 750 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% 
SDS, 1 mM DTT, 2 µM ADP-HPD PARG inhibitor (Merck) and protease inhibitors (Pierce 
protease inhibitor tablets, EDTA-free, Thermo Fisher Scientific). Cell lysates were briefly sonicated 
on ice to shear DNA and cleared by centrifugation (20,817 xg, 15 min) at 4 °C. The cleared cell 
lysates were incubated with pre-equilibrated 75 µl packed volume of anti-c-Myc-agarose resin 
(9E10; Thermo Fisher Scientific or Takara Bio) for 3 h rotating at 4 °C. Resin samples were washed 
9 times with 4 ml lysis buffer and 3 times with 1 ml PARP assay buffer (50 mM HEPES–NaOH pH 
7.5, 150 mM NaCl, 0.01% Triton X-100, 10% glycerol, 1 mM DTT). After the final wash step, 75 
µl of PAR assay buffer were added to the resin and 40 µl of the suspension removed for analysis by 
SDS-PAGE and Commassie Brilliant Blue staining to estimate protein levels. The total remaining 
sample volumes were adjusted to 54 µl by addition of 27.5 µl of PARP assay buffer. 6 µl of 10x 
NAD+ stock (10 mM NAD+ and 5 µCi/6 µl 32P-NAD+ (Perkin Elmer)) were added to each sample 
and PARP reactions performed for 30 min at 30 °C on a horizontal shaker at 800 rpm. 30 µl of 
suspension were taken from each sample, boiled with 2x SDS sample buffer and comparable 
amounts of MYC2-Tankyrases, based on previous protein level estimates, analysed by SDS-PAGE 
and Coomassie Brilliant Blue staining. The gel was dried on a gel dryer and exposed to a 
phosphoimager plate (GE Healthcare) for 24 h. If MYC2-Tankyrase levels were low, their levels in 
the PARylation reaction were analysed by Western blotting, using equivalent amounts of 
immunoprecipitate samples set aside prior to the in-vitro PARylation reaction. Endogenous 
PARylation (prior to the in-vitro PARylation reaction) was assessed by Western blotting using an 
anti-PAR antibody. 
PAR chains were analysed essentially as described previously (Alvarez-Gonzalez and 
Jacobson, 1987; Panzeter and Althaus, 1990), as follows. The PARP assay samples remaining upon 
SDS-PAGE analysis were precipitated by addition of an equal volume of ice-cold 40% (w/v) 
trichloroacetic acid (TCA) and incubated on ice for 15 minutes. The resins were settled by slow 
centrifugation (1,000 xg, 10 s) and the supernatants recovered. Precipitates were collected by 
centrifugation (16,300 xg, 10 min) and the pellets washed 3 times with 100 µl 5% TCA followed by 
2 wash steps with 100 µl ice-cold diethyl ether (Sigma-Aldrich). The pellets were dried using a 
Micro-Cenvac NB-503CIR vacuum concentrator at 50 °C for 10 min at 2,500 rpm. The PAR chains 
were detached from the precipitated material by resuspending the dried pellets in 100 µl of 10 mM 
Tris (base), 1 mM EDTA, pH 12 and incubated for 3 hours at 60 °C. PAR was extracted with 100 µl 
of phenol/chloroform/isoamyl alcohol (25:24:1) and the aqueous phase recovered followed by two 
rounds of phenol back-extraction with 100 µl chloroform/isoamyl alcohol (24:1). After the final 
phenol back-extraction, the samples were dried in the vacuum concentrator at 50 °C for 60 min at 
2,500 rpm. PAR was dissolved in 10 µl of PAR sample buffer (50% urea, 25 mM NaCl, 4 mM 
EDTA (pH 8.0), 0.02% xylene cyanol, 0.02% bromophenol blue). The amounts of 32P-labelled PAR 
chains were quantified by Cerenkov counting and equal counts per minute (cpm) of samples were 
loaded onto a 40% acrylamide/bisacrylamide (19:1) sequencing gel (kuroGEL Verti 1824), except 
for the negative control samples (vector only and TNKS2 G1032WT2), for which the whole sample 
was loaded. The sequencing gel electrophoresis was performed in 1x TBE running buffer using a 
constant current of 25 mA. The electrophoresis was stopped when the bromophenol blue band had 
migrated 11 cm from the bottom of the wells. The gel was fixed for 1 h with 40% methanol, 10% 
acetic acid, 3% glycerol (to protect it from cracking during drying) and dried using a temperature 
gradient cycle to 60 °C for 2-3 h. The gel was exposed for 24 h to a phosphoimager plate (GE 
Healthcare). Phosphoimager plates were read using a Typhoon FL9500 biomolecular imager (GE 
Healthcare) and analysed using ImageQuant TL. Xylene cyanol (XC) and bromophenol blue (BPB) 
were used to determine the PAR chain length (Alvarez-Gonzalez and Jacobson, 2011). 
 
Tankyrase-Tankyrase co-immunoprecipitation 
HEK293T cells were seeded on 10-cm cell culture dishes at 6 x 106 cells per dish. On the 
next day, cells were transfected with expression plasmids for pLP-tripleFLAG SD-TNKS (wild-
type or T1049RT1) or pLP-tripleFLAG SD-TNKS2 (wild-type or R896TT2) as bait or empty vector 
as control (10 µg) and co-transfected with the indicated pLP-dMYC SD-TNKS or pLP-dMYC SD-
TNKS2 constructs (10 µg) using calcium phosphate. After 24 h, cells were scraped in ice-cold PBS 
and collected by centrifugation. Cells were lysed in 900 µl of lysis buffer containing 50 mM 
HEPES-NaOH pH 7.5, 200 mM NaCl, 0.2% Triton X-100, 10% glycerol, 5 mM DTT and protease 
inhibitors (Pierce protease inhibitor tablets, EDTA-free, Thermo Fisher Scientific). Cell lysates 
were briefly sonicated on ice to shear genomic DNA and clarified by centrifuction at 20,817 x g for 
15 min at 4 °C. Immunoprecipitation was performed with 30 µl of packed, washed anti-FLAG M2 
agarose (Sigma), rotating for 3 h at 4 °C. The immunoprecipitates were washed five times with 1 ml 
lysis buffer (without protease inhibitors and with only 1 mM DTT). Immunoprecipitated proteins 
were recovered by boiling the resin in 50 µl of 2x SDS-PAGE sample buffer. Lysate samples 
(input) and immunoprecipitates were analysed by SDS-PAGE (10%) and Western blotting. Western 
blots were imaged using an Odyssey infrared imaging system (LI-COR). 
 
Endogenous AXIN1 immunoprecipitation 
HEK293T cells were seeded on 10-cm cell culture dishes at 6 x 106 cells per dish. On the 
next day, the media were replaced with DMEM containing 0.3% FBS. (Serum starvation was 
performed to match conditions used in the luciferase reporter assays.) Each dish was transfected 
with 10 µg pLP-dMYC SD empty vector or the indicated TNKS2 constructs using calcium 
phosphate. In order to maintain its limiting cellular concentrations, we did not overexpress AXIN 
bait protein but instead relied on endogenous AXIN1. 24 h post-transfection, cells were scraped in 
ice-cold PBS and cell pellets lysed in 0.75 ml of the stringent RIPA buffer (50 mM HEPES-NaOH 
pH 7.5, 150 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM DTT, 2 
µM ADP-HPD PARG inhibitor (Merck) and protease inhibitors (Pierce protease inhibitor tablets, 
EDTA-free, Thermo Fisher Scientific). Cell lysates were briefly sonicated on ice to shear DNA and 
cleared by centrifugation (20,817 xg, 15 min) at 4 °C. Cleared cell lysates were incubated rotating 
at 4 °C overnight with rabbit anti-AXIN1 (C76H11 clone, Cell Signaling Technologies) at a 1:50 
dilution, as recommended by supplier. Rabbit IgG antibody (sc-2027, Santa Cruz Biotechnology), 
at comparable concentration, was used as a negative control. 25 µl of pre-equilibrated Pierce 
Protein A/G magnetic resin (Thermo) were incubated with the samples for 2 h rotating at 4 °C. The 
resin samples were washed extensively: 6 times with 1 ml RIPA buffer (without ADP-HPD and 
protease inhibitors) each. Immunoprecipitated proteins were recovered by boiling the resin samples 
in 60 µl of 2x SDS-PAGE loading buffer. Lysate samples (input) and immunoprecipitates were 
analysed by SDS-PAGE and Western blotting. Western blots were imaged using an Odyssey 
infrared imaging system (LI-COR). 
 
Assessment of Tankyrase inhibition by XAV939 
HEK293T cells were seeded on six-well cell culture dishes at 3.5 x 105 cells per well. On the 
next day, cells were transfected in Opti-MEM II (Thermo Fisher Scientific / Gibco) with expression 
plasmids for pLP-dMYC SD-TNKS2 or empty vector as control (1 µg) using Lipofectamine 2000 
in a DNA:transfectant ratio of 1:3. Four h after transfection complex addition, media were changed 
for DMEM with 0.3% FBS, to match conditions of the luciferase reporter assay. XAV939 was 
included in a two-fold dilution series from 9.8 nM to 10 µM at the media change step, maintaining a 
constant DMSO concentration of 0.2%. Twenty h after XAV939 treatment, cells were lysed in 50 
mM HEPES-NaOH pH 7.5, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% Triton X-
100, 5 mM DTT, 2 µM ADP-HPD PARG inhibitor (Merck) and protease inhibitors (Pierce protease 
inhibitor tablets, EDTA-free, Thermo Fisher Scientific). Cell lysates were cleared by centrifugation 
(20,817 xg, 15 min) at 4 °C. MYC2-TNKS2 was immunoprecipitated using 20 µl of packed anti-
MYC 9E10 agarose (Takara) per sample on a rotating wheel for 3 h at 4 °C. Immunoprecipitates 
were washed 3 times with 1 ml wash buffer (as lysis buffer, but without PARG inhibitor, protease 
inhibitors and containing only 1 mM DTT). Resin samples were taken up in 20 µl 4x SDS sample 
buffer, boiled and processed for SDS-PAGE and Western blotting. 
 
Cell lysate fractionations by gel filtration chromatography 
 HEK293T cells were seeded on 10-cm cell culture dishes at 6 x 106 cells per dish. On the 
next day, cells were transfected with the indicated pLP-dMYC SD-TNKS or pLP-dMYC SD-
TNKS2 constructs or empty vector (20 µg) using calcium phosphate. Cells were maintained in 
DMEM with 10% FBS. After 24 h, cells were washed in ice-cold PBS, scraped in ice-cold PBS, 
collected by centrifugation and flash-frozen in liquid nitrogen. Cells were lysed in 600 µl of 
lysis/fractionation buffer containing 50 mM HEPES-NaOH pH 7.5, 200 mM NaCl, 0.2% Triton X-
100, 2 mM TCEP and protease inhibitors (Pierce protease inhibitor tablets, EDTA-free, Thermo 
Fisher Scientific). Lysates were briefly sonicated (3 s at 20% output on a Vibra-Cell sonicator 
(Sonics & Materials) equipped with a micro-tip). After 10 min extraction time on ice, cell lysates 
were cleared by centrifugation (20,817 xg, 15 min) at 4 °C. 500 µl of cleared lysates were subjected 
to size exclusion chromatography on a Superose 6 10/300 GL column (GE Healthcare) equilibrated 
in lysis/fractionation buffer with a flow rate of 400 µl/min and collection of 400-µl fractions. 200 µl 
of each fraction were subjected to acetone precipitation with 800 µl acetone at -20 °C. Precipitates 
were collected by centrifugation (20,817 xg, 10 min) at 4 °C, air-dried and taken up in 10 µl of 2x 
SDS sample buffer. 5 µl of lysate (input) and fraction samples (total 10 µl corresponding to 200 µl 
of fractionated sample) were analysed by SDS-PAGE and Western blotting. The column was 
calibrated using a gel filtration standard protein mix (BIO-RAD, 151-1901) under identical 
fractionation conditions. Note that apparent molecular weights of eluting proteins are not only 
sensitive to polymeric status but also to interactions in the cell lysates and protein/protein complex 
shape. 
 
Fluorescence microscopy 
 HeLa or SW480 cells were plated in 6-well dishes with glass coverslips (200,000 
cells/well). On the following day, the media were changed for Opti-MEM II (Thermo Fisher 
Scientific / Gibco), and the cells were transiently transfected with 1 µg of the indicated MYC2-, 
mCitrine- or mCherry-tagged TNKS2 constructs each using Lipofectamine 2000 (Thermo Fisher 
Scientific / Invitrogen) in a DNA:transfectant ratio of 1:3. 4 h after complex addition, transfection 
mix was replaced by DMEM containing 0.3% FBS supplemented with either DMSO (0.04%) or 2 
µM XAV939. 20 h after media change, cells were fixed by addition of 4% formaldehyde 
(AMRESCO) and incubation at 37 °C for 10 min. For immunofluorescence microscopy, cells were 
washed once with PBS, permeabilised with 0.2% Triton X-100 in PBS for 10 min. Permeabilisation 
buffer was replaced by PBS. Non-specific epitopes were blocked with blocking solution (PBS, 5% 
(w/v) dry milk powder, 10% FBS, 0.05% Tween-20) for 1 h. Cells were immunostained with 
primary (anti-MYC 9E10 (1:1000, MA1-81358, Thermo Fisher Scientific), anti-AXIN2 (1:100, 
76G6, Cell Signaling Technology) and secondary antibodies in blocking solution for 1 h, 
respectively, and DAPI-stained to visualise DNA. DAPI staining without permeabilisation was 
performed for HeLa cells expressing mCitrine and mCherry fusion proteins. Coverlips were 
mounted on glass slides using fluorescent mounting media (DAKO). Cells were imaged on an 
LSM710 confocal laser scanning microscope (Zeiss). Micrographs were acquired in the Zen 
software (Zeiss) and channels separated using Adobe Photoshop. A uniform exposure adjustment 
across all panels was performed for Figures 6B and S7C and D to enhance visibility of localisation 
features in the figures. 
  
Supplemental References 
Adams, P.D., Afonine, P.V., Bunkóczi, G., Chen, V.B., Davis, I.W., Echols, N., Headd, J.J., Hung, 
L.-W., Kapral, G.J., Grosse-Kunstleve, R.W., et al. (2010). PHENIX: a comprehensive Python-
based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213–
221. 
Alvarez-Gonzalez, R., and Jacobson, M.K. (1987). Characterization of polymers of adenosine 
diphosphate ribose generated in vitro and in vivo. Biochemistry 26, 3218–3224. 
Alvarez-Gonzalez, R., and Jacobson, M.K. (2011). Quantification of poly(ADP-ribose) in vitro: 
determination of the ADP-ribose chain length and branching pattern. Methods Mol. Biol. 780, 35–
46. 
Arnold, K., Bordoli, L., Kopp, J., and Schwede, T. (2006). The SWISS-MODEL workspace: a web-
based environment for protein structure homology modelling. Bioinformatics 22, 195–201. 
Collaborative Computational Project, N.4. (1994). The CCP4 suite: programs for protein 
crystallography. Acta Crystallogr. D Biol. Crystallogr. 50, 760–763. 
Colwill, K., Wells, C., Elder, K., Goudreault, M., Hersi, K., Kulkarni, S., Hardy, W.R., Pawson, T., 
and Morin, G. (2006). Modification of the Creator recombination system for proteomics 
applications – improved expression by addition of splice sites. BMC Biotechnol 6, 13. 
Emsley, P., Lohkamp, B., Scott, W.G., and Cowtan, K. (2010). Features and development of Coot. 
Acta Cryst (2010). D66, 486-501 [Doi:10.1107/S0907444910007493] 1–16. 
Foadi, J., Aller, P., Alguel, Y., Cameron, A., Axford, D., Owen, R.L., Armour, W., Waterman, 
D.G., Iwata, S., and Evans, G. (2013). Clustering procedures for the optimal selection of data sets 
from multiple crystals in macromolecular crystallography. Acta Crystallogr. D Biol. Crystallogr. 
69, 1617–1632. 
Francis, N.J., Saurin, A.J., Shao, Z., and Kingston, R.E. (2001). Reconstitution of a functional core 
polycomb repressive complex. Molecular Cell 8, 545–556. 
Gasteiger, E., Hoogland, C., Gattiker, A., and Wilkins, M.R. (2005). Protein identification and 
analysis tools on the ExPASy server (Totowa, NJ: Humana Press). 
Guettler, S., LaRose, J., Petsalaki, E., Gish, G., Scotter, A., Pawson, T., Rottapel, R., and Sicheri, F. 
(2011). Structural basis and sequence rules for substrate recognition by Tankyrase explain the basis 
for cherubism disease. Cell 147, 1340–1354. 
Kabsch, W. (2010).  XDS. Acta Crystallogr. D Biol. Crystallogr. 66, 125–132. 
Karplus, P.A., and Diederichs, K. (2012). Linking crystallographic model and data quality. Science 
336, 1030–1033. 
Kim, C.A., Gingery, M., Pilpa, R.M., and Bowie, J.U. (2002). The SAM domain of polyhomeotic 
forms a helical polymer. Nature Structural & Molecular Biology 9, 453–457. 
Krissinel, E., and Henrick, K. (2007). Inference of macromolecular assemblies from crystalline 
state. 
Larkin, M.A., Blackshields, G., Brown, N.P., and Chenna, R. (2007). Clustal W and Clustal X 
version 2.0. 
Lees, J.G., Smith, B.R., Wien, F., Miles, A.J., and Wallace, B.A. (2004). CDtool-an integrated 
software package for circular dichroism spectroscopic data processing, analysis, and archiving. 
Analytical Biochemistry 332, 285–289. 
Li, M.Z., and Elledge, S.J. (2007). Harnessing homologous recombination in vitro to generate 
recombinant DNA via SLIC. Nat Meth 4, 251–256. 
McCoy, A.J., Grosse-Kunstleve, R.W., Adams, P.D., Winn, M.D., Storoni, L.C., and Read, R.J. 
(2007). Phaser crystallographic software. J Appl Crystallogr 40, 658–674. 
Panzeter, P.L., and Althaus, F.R. (1990). High resolution size analysis of ADP-ribose polymers 
using modified DNA sequencing gels. Nucleic Acids Research 18, 2194. 
Patke, S., Maheshwari, R., Litt, J., Srinivasan, S., Aguilera, J.J., Colón, W., and Kane, R.S. (2012). 
Influence of the carboxy terminus of serum amyloid A on protein oligomerization, misfolding, and 
fibril formation. Biochemistry 51, 3092–3099. 
Pettersen, E.F., Goddard, T.D., Huang, C.C., Couch, G.S., Greenblatt, D.M., Meng, E.C., and 
Ferrin, T.E. (2004). UCSF Chimera--a visualization system for exploratory research and analysis. J 
Comput Chem 25, 1605–1612. 
Šali, A., Potterton, L., and Yuan, F. (1995). Evaluation of comparative protein modeling by 
MODELLER. Proteins: Structure. 
Veeman, M.T., Slusarski, D.C., Kaykas, A., Louie, S.H., and Moon, R.T. (2003). Zebrafish prickle, 
a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements. Curr. Biol. 13, 
680–685. 
Waterhouse, A.M., Procter, J.B., Martin, D.M.A., Clamp, M., and Barton, G.J. (2009). Jalview 
Version 2--a multiple sequence alignment editor and analysis workbench. Bioinformatics 25, 1189–
1191. 
Whitmore, L., and Wallace, B.A. (2004). DICHROWEB, an online server for protein secondary 
structure analyses from circular dichroism spectroscopic data. Nucleic Acids Research 32, W668–
W673. 
Whitmore, L., and Wallace, B.A. (2008). Protein secondary structure analyses from circular 
dichroism spectroscopy: Methods and reference databases. Biopolymers 89, 392–400. 
Winn, M.D., Ballard, C.C., Cowtan, K.D., Dodson, E.J., Emsley, P., Evans, P.R., Keegan, R.M., 
Krissinel, E.B., Leslie, A.G.W., McCoy, A., et al. (2011). Overview of the CCP4 suite and current 
developments. Acta Crystallogr. D Biol. Crystallogr. 67, 235–242. 
 
Highlights 
- SAM domain crystal structures reveal mechanism of Tankyrase polymerisation 
- Catalysis-independent Tankyrase scaffolding drives Wnt-β-catenin signalling 
- Tankyrase polymerisation supports PARP activity and AXIN binding 
 
In Brief 
Catalysis-independent scaffolding by Tankyrase supports Wnt-β-catenin signalling. Scaffolding is 
mediated by AXIN-binding ankyrin repeat clusters and a polymerising SAM domain. In a structure-
function approach, Mariotti et al. show that polymerisation supports Tankyrase PARP activity and 
enables avidity-dependent AXIN binding. 
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